<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d187" origId="Bumetanide"><sentence id="DrugDDI.d187.s0" origId="s0" text="- Drugs with ototoxic potential: Especially in the presence of impaired renal function, the use of parenterally administered bumetanide in patients to whom aminoglycoside antibiotics are also being given should be avoided, except in life-threatening conditions."><entity id="DrugDDI.d187.s0.e0" origId="s0.p0" charOffset="2-7" type="drug" text="Drugs"/><entity id="DrugDDI.d187.s0.e1" origId="s0.p7" charOffset="125-135" type="drug" text="bumetanide"/><entity id="DrugDDI.d187.s0.e2" origId="s0.p9" charOffset="156-182" type="drug" text="aminoglycoside antibiotics"/><pair id="DrugDDI.d187.s0.p0" e1="DrugDDI.d187.s0.e0" e2="DrugDDI.d187.s0.e1" interaction="false"/><pair id="DrugDDI.d187.s0.p1" e1="DrugDDI.d187.s0.e0" e2="DrugDDI.d187.s0.e2" interaction="false"/><pair id="DrugDDI.d187.s0.p2" e1="DrugDDI.d187.s0.e1" e2="DrugDDI.d187.s0.e2" interaction="true"/></sentence><sentence id="DrugDDI.d187.s1" origId="s1" text="- Drugs with nephrotoxic potential: There has been no experience on the concurrent use of bumetanide with drugs known to have a nephrotoxic potential."><entity id="DrugDDI.d187.s1.e0" origId="s1.p20" charOffset="2-7" type="drug" text="Drugs"/><entity id="DrugDDI.d187.s1.e1" origId="s1.p28" charOffset="90-100" type="drug" text="bumetanide"/><entity id="DrugDDI.d187.s1.e2" origId="s1.p29" charOffset="106-111" type="drug" text="drugs"/><pair id="DrugDDI.d187.s1.p0" e1="DrugDDI.d187.s1.e0" e2="DrugDDI.d187.s1.e1" interaction="false"/><pair id="DrugDDI.d187.s1.p1" e1="DrugDDI.d187.s1.e0" e2="DrugDDI.d187.s1.e2" interaction="false"/><pair id="DrugDDI.d187.s1.p2" e1="DrugDDI.d187.s1.e1" e2="DrugDDI.d187.s1.e2" interaction="false"/></sentence><sentence id="DrugDDI.d187.s2" origId="s2" text="Therefore, the simultaneous administration of these drugs should be avoided."><entity id="DrugDDI.d187.s2.e0" origId="s2.p36" charOffset="52-57" type="drug" text="drugs"/></sentence><sentence id="DrugDDI.d187.s3" origId="s3" text="- Lithium: Lithium should generally not be given with diuretics (such as bumetanide) because they reduce its renal clearance and add a high risk of lithium toxicity."><entity id="DrugDDI.d187.s3.e0" origId="s3.p40" charOffset="2-9" type="drug" text="Lithium"/><entity id="DrugDDI.d187.s3.e1" origId="s3.p42" charOffset="11-18" type="drug" text="Lithium"/><entity id="DrugDDI.d187.s3.e2" origId="s3.p48" charOffset="54-63" type="drug" text="diuretics"/><entity id="DrugDDI.d187.s3.e3" origId="s3.p50" charOffset="73-83" type="drug" text="bumetanide"/><pair id="DrugDDI.d187.s3.p0" e1="DrugDDI.d187.s3.e0" e2="DrugDDI.d187.s3.e1" interaction="false"/><pair id="DrugDDI.d187.s3.p1" e1="DrugDDI.d187.s3.e0" e2="DrugDDI.d187.s3.e2" interaction="false"/><pair id="DrugDDI.d187.s3.p2" e1="DrugDDI.d187.s3.e0" e2="DrugDDI.d187.s3.e3" interaction="false"/><pair id="DrugDDI.d187.s3.p3" e1="DrugDDI.d187.s3.e1" e2="DrugDDI.d187.s3.e2" interaction="true"/><pair id="DrugDDI.d187.s3.p4" e1="DrugDDI.d187.s3.e1" e2="DrugDDI.d187.s3.e3" interaction="true"/><pair id="DrugDDI.d187.s3.p5" e1="DrugDDI.d187.s3.e2" e2="DrugDDI.d187.s3.e3" interaction="false"/></sentence><sentence id="DrugDDI.d187.s4" origId="s4" text="- Probenecid: Pretreatment with probenecid reduces both the natriuresis and hyperreninemia produced by bumetanide."><entity id="DrugDDI.d187.s4.e0" origId="s4.p60" charOffset="2-12" type="drug" text="Probenecid"/><entity id="DrugDDI.d187.s4.e1" origId="s4.p63" charOffset="32-42" type="drug" text="probenecid"/><entity id="DrugDDI.d187.s4.e2" origId="s4.p70" charOffset="103-113" type="drug" text="bumetanide"/><pair id="DrugDDI.d187.s4.p0" e1="DrugDDI.d187.s4.e0" e2="DrugDDI.d187.s4.e1" interaction="false"/><pair id="DrugDDI.d187.s4.p1" e1="DrugDDI.d187.s4.e0" e2="DrugDDI.d187.s4.e2" interaction="false"/><pair id="DrugDDI.d187.s4.p2" e1="DrugDDI.d187.s4.e1" e2="DrugDDI.d187.s4.e2" interaction="true"/></sentence><sentence id="DrugDDI.d187.s5" origId="s5" text="This antagonistic effect of probenecid on bu-metanide natriuresis is not due to a direct action on sodium excretion but is probably secondary to its inhibitory effect on renal tubular secretion of bumetanide."><entity id="DrugDDI.d187.s5.e0" origId="s5.p72" charOffset="28-38" type="drug" text="probenecid"/><entity id="DrugDDI.d187.s5.e1" origId="s5.p77" charOffset="99-105" type="drug" text="sodium"/><entity id="DrugDDI.d187.s5.e2" origId="s5.p83" charOffset="197-207" type="drug" text="bumetanide"/><pair id="DrugDDI.d187.s5.p0" e1="DrugDDI.d187.s5.e0" e2="DrugDDI.d187.s5.e1" interaction="false"/><pair id="DrugDDI.d187.s5.p1" e1="DrugDDI.d187.s5.e0" e2="DrugDDI.d187.s5.e2" interaction="true"/><pair id="DrugDDI.d187.s5.p2" e1="DrugDDI.d187.s5.e1" e2="DrugDDI.d187.s5.e2" interaction="false"/></sentence><sentence id="DrugDDI.d187.s6" origId="s6" text="Thus, probenecid should not be administered concurrently with bumetanide."><entity id="DrugDDI.d187.s6.e0" origId="s6.p85" charOffset="6-16" type="drug" text="probenecid"/><entity id="DrugDDI.d187.s6.e1" origId="s6.p91" charOffset="62-72" type="drug" text="bumetanide"/><pair id="DrugDDI.d187.s6.p0" e1="DrugDDI.d187.s6.e0" e2="DrugDDI.d187.s6.e1" interaction="true"/></sentence><sentence id="DrugDDI.d187.s7" origId="s7" text="- Indomethacin: Indomethacin blunts the increases in urine volume and sodium excretion seen during bumetanide treatment and inhibits the bumetanide-induced increase in plasma renin activity."><entity id="DrugDDI.d187.s7.e0" origId="s7.p92" charOffset="2-14" type="drug" text="Indomethacin"/><entity id="DrugDDI.d187.s7.e1" origId="s7.p94" charOffset="16-28" type="drug" text="Indomethacin"/><entity id="DrugDDI.d187.s7.e2" origId="s7.p99" charOffset="70-76" type="drug" text="sodium"/><entity id="DrugDDI.d187.s7.e3" origId="s7.p104" charOffset="137-147" type="drug" text="bumetanide"/><pair id="DrugDDI.d187.s7.p0" e1="DrugDDI.d187.s7.e0" e2="DrugDDI.d187.s7.e1" interaction="false"/><pair id="DrugDDI.d187.s7.p1" e1="DrugDDI.d187.s7.e0" e2="DrugDDI.d187.s7.e2" interaction="false"/><pair id="DrugDDI.d187.s7.p2" e1="DrugDDI.d187.s7.e0" e2="DrugDDI.d187.s7.e3" interaction="false"/><pair id="DrugDDI.d187.s7.p3" e1="DrugDDI.d187.s7.e1" e2="DrugDDI.d187.s7.e2" interaction="false"/><pair id="DrugDDI.d187.s7.p4" e1="DrugDDI.d187.s7.e1" e2="DrugDDI.d187.s7.e3" interaction="true"/><pair id="DrugDDI.d187.s7.p5" e1="DrugDDI.d187.s7.e2" e2="DrugDDI.d187.s7.e3" interaction="false"/></sentence><sentence id="DrugDDI.d187.s8" origId="s8" text="Concurrent therapy with bumetanide is thus not recommended."><entity id="DrugDDI.d187.s8.e0" origId="s8.p107" charOffset="24-34" type="drug" text="bumetanide"/></sentence><sentence id="DrugDDI.d187.s9" origId="s9" text="- Antihypertensives: Bumetanide may potentiate the effect of various antihypertensive drugs, necessitating a reduction in the dosage of these drugs."><entity id="DrugDDI.d187.s9.e0" origId="s9.p112" charOffset="2-19" type="drug" text="Antihypertensives"/><entity id="DrugDDI.d187.s9.e1" origId="s9.p114" charOffset="21-31" type="drug" text="Bumetanide"/><entity id="DrugDDI.d187.s9.e2" origId="s9.p118" charOffset="69-91" type="drug" text="antihypertensive drugs"/><entity id="DrugDDI.d187.s9.e3" origId="s9.p122" charOffset="142-147" type="drug" text="drugs"/><pair id="DrugDDI.d187.s9.p0" e1="DrugDDI.d187.s9.e0" e2="DrugDDI.d187.s9.e1" interaction="false"/><pair id="DrugDDI.d187.s9.p1" e1="DrugDDI.d187.s9.e0" e2="DrugDDI.d187.s9.e2" interaction="false"/><pair id="DrugDDI.d187.s9.p2" e1="DrugDDI.d187.s9.e0" e2="DrugDDI.d187.s9.e3" interaction="false"/><pair id="DrugDDI.d187.s9.p3" e1="DrugDDI.d187.s9.e1" e2="DrugDDI.d187.s9.e2" interaction="true"/><pair id="DrugDDI.d187.s9.p4" e1="DrugDDI.d187.s9.e1" e2="DrugDDI.d187.s9.e3" interaction="false"/><pair id="DrugDDI.d187.s9.p5" e1="DrugDDI.d187.s9.e2" e2="DrugDDI.d187.s9.e3" interaction="false"/></sentence><sentence id="DrugDDI.d187.s10" origId="s10" text="- Digoxin: Interaction studies in humans have shown no effect on digoxin blood levels."><entity id="DrugDDI.d187.s10.e0" origId="s10.p123" charOffset="2-9" type="drug" text="Digoxin"/></sentence><sentence id="DrugDDI.d187.s11" origId="s11" text="- Anticoagulants: Interaction studies in humans have shown bumetanide to have no effect on warfarin metabolism or on plasma prothrombin activity."><entity id="DrugDDI.d187.s11.e0" origId="s11.p132" charOffset="2-16" type="drug" text="Anticoagulants"/><entity id="DrugDDI.d187.s11.e1" origId="s11.p139" charOffset="59-69" type="drug" text="bumetanide"/><entity id="DrugDDI.d187.s11.e2" origId="s11.p142" charOffset="91-99" type="drug" text="warfarin"/><pair id="DrugDDI.d187.s11.p0" e1="DrugDDI.d187.s11.e0" e2="DrugDDI.d187.s11.e1" interaction="false"/><pair id="DrugDDI.d187.s11.p1" e1="DrugDDI.d187.s11.e0" e2="DrugDDI.d187.s11.e2" interaction="false"/><pair id="DrugDDI.d187.s11.p2" e1="DrugDDI.d187.s11.e1" e2="DrugDDI.d187.s11.e2" interaction="false"/></sentence></document>